Katakura  Industries  Co.,Ltd. Logo

Katakura Industries Co.,Ltd.

Diversified company in real estate, pharmaceuticals, machinery, and textiles.

3001 | T

Overview

Corporate Details

ISIN(s):
JP3211400001
LEI:
Country:
Japan
Address:
中央区明石町6番4号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Katakura Industries Co., Ltd. is a diversified company with operations spanning multiple sectors. The company's core business segments include Real Estate, Pharmaceuticals, Machinery, and Textiles. In real estate, its activities involve the management of commercial facilities, leasing of properties, and the development and utilization of company-owned land. The pharmaceutical division manufactures and sells medications, with a focus on treatments for cardiovascular illnesses such as angina pectoris and cardiac infarction. Additionally, the company engages in the manufacture and sale of mechanical equipment and maintains its legacy operations in the textile industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 04:45
Interim / Quarterly Report
確認書
Japanese 8.7 KB
2025-08-13 04:43
Interim / Quarterly Report
半期報告書-第117期(2025/01/01-2025/12/31)
Japanese 246.8 KB
2025-06-11 09:00
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.4 KB
2025-04-03 09:00
AGM Information
臨時報告書
Japanese 23.6 KB
2025-03-28 05:22
Governance Information
内部統制報告書-第116期(2024/01/01-2024/12/31)
Japanese 23.3 KB
2025-03-28 05:18
Registration Form
確認書
Japanese 8.7 KB
2025-03-28 05:16
Annual Report
有価証券報告書-第116期(2024/01/01-2024/12/31)
Japanese 1.3 MB
2024-09-11 09:00
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.4 KB
2024-08-09 08:40
Interim / Quarterly Report
確認書
Japanese 8.7 KB
2024-08-09 08:38
Interim / Quarterly Report
半期報告書-第116期(2024/01/01-2024/12/31)
Japanese 254.9 KB
2024-05-14 08:47
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-05-14 08:45
Quarterly Report
四半期報告書-第116期第1四半期(2024/01/01-2024/03/31)
Japanese 192.4 KB
2024-04-03 09:09
AGM Information
臨時報告書
Japanese 30.7 KB
2024-03-28 05:36
Governance Information
内部統制報告書-第115期(2023/01/01-2023/12/31)
Japanese 23.0 KB
2024-03-28 05:33
Registration Form
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all Katakura Industries Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Katakura Industries Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Katakura Industries Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Annexon, Inc. Logo
Developing C1q inhibitors for autoimmune, neurodegenerative, and ophthalmic diseases.
United States of America
ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea
065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania
ATB
Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.